Certified by Founder Lodge
Apollo Therapeutics
United Kingdom - Cambridge, England
START UP
1 Disclosed Funding Rounds $226,500,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Apollo Therapeutics is a biopharmaceutical company rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough discoveries. Through deep relat
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 11 ,2023 | Series C | $226,500,000 | |
| January, 03 ,2024 | Series C | $33,500,000.00 |
Rock Springs Capital
Patient Square Capital
M&G plc
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
FOVC | $2,000,000 | (Jan 16, 2026)
CYB3R OPERATIONS | $5,400,000 | (Jan 16, 2026)
Project Eleven | $20,000,000 | (Jan 16, 2026)
depthfirst | $40,000,000 | (Jan 16, 2026)
Quadric | $30,000,000 | (Jan 16, 2026)
